Spine | Jotup

IDE STUDY DATA DEMONSTRATE SHORTER LENGTH OF STAY AND RECOVERY TIME FOR PATIENTS TREATED WITH LIMIFLEX™ DYNAMIC SAGITTAL TETHER™ (DST) STABILIZATION

Retrieved on:

Thursday, June 1, 2023

SAN CARLOS, Calif., June 1, 2023 /PRNewswire/ -- A recently published paper in The Open Orthopaedics Journal compared outcomes for degenerative spondylolisthesis surgery using decompression and Empirical Spine's LimiFlex™ Dynamic Sagittal Tether™ (DST) stabilization versus transforaminal lumbar interbody fusion (TLIF). The interim results of the FDA IDE trial showed both approaches led to substantial improvements in pain and function within the initial postoperative period, but the DST group had shorter hospital stays, earlier return to work, and higher patient-reported activity levels three months post-surgery.

Key Points:

The analysis evaluated the 90-day outcomes of IDE study patients who received the LimiFlex DST versus TLIF stabilization after decompression surgery for degenerative spondylolisthesis, a condition in which a vertebra slips forward on the vertebra below it, causing pain, numbness, and weakness.
However, the data showed that compared to TLIF, the DST procedure was shorter, less invasive, and resulted in a faster discharge.
The FDA IDE trial is ongoing, and further data will be collected and analyzed to assess the long-term outcomes of decompression and DST stabilization versus TLIF.
Caution: The LimiFlex Dynamic Sagittal Tether is an investigational device in the United States and is limited by law to investigational use.

BRIAN MAY + FRIENDS: "STAR FLEET PROJECT" Special 40th Anniversary Edition

Retrieved on:

Thursday, June 1, 2023

LOS ANGELES, June 1, 2023 /PRNewswire/ -- When Queen took a break for the first part of 1983, Brian May put his time to good use. Waking up one morning in Los Angeles, he decided to phone a few friends and invite them to collaborate on some tracks in California's famous Record Plant studios. The resulting collaboration was a great success, and Brian would later mold the recordings into a unique mini-album, Brian May + Friends: Star Fleet Project.

Key Points:

– Brian May
LOS ANGELES, June 1, 2023 /PRNewswire/ -- When Queen took a break for the first part of 1983, Brian May put his time to good use.
The resulting collaboration was a great success, and Brian would later mold the recordings into a unique mini-album, Brian May + Friends: Star Fleet Project.
This third release in the "Brian May Gold Series" offers an extensively revisited and expanded box set edition of these legendary sessions.
Containing two CDs, one vinyl LP, and a vinyl single, as well as other collector's items, Brian May + Friends: Star Fleet Sessions will be launched as a Deluxe Edition box set, worldwide on July 14th.

Distinguished Cardiac Surgeon Dr. Abbas Ardehali Joins Medcura's Board of Directors

Retrieved on:

Thursday, June 1, 2023

David Geffen School of Medicine at UCLA, Surgeon, Bleeding, Powder, Infection, Spine, Medicine, Paralysis, Hemostasis, Pet, Abbas Ardehali, UCLA, FDA, Nerve, Trauma, Dentistry

RIVERDALE, Md., June 1, 2023 /PRNewswire/ -- Medcura Inc. welcomes Dr. Abbas Ardehali to its Board of Directors.

Key Points:

RIVERDALE, Md., June 1, 2023 /PRNewswire/ -- Medcura Inc. welcomes Dr. Abbas Ardehali to its Board of Directors.
Dr. Ardehali is a professor of surgery and medicine in the division of cardiothoracic surgery at the David Geffen School of Medicine at UCLA.
Dr. Ardehali also serves as director of the UCLA Heart and Lung Transplant program.
"Dr. Ardehali is a fantastic addition to our board of directors.

The Inner Circle Acknowledges, Steven M. Carrell as a Distinguished Healthcare Professional for his contributions to the Chiropractic Field

Retrieved on:

Wednesday, May 31, 2023

Bachelor of Science, Headache, Neck pain, Massage, Mont Belvieu, Texas, Quality of life, Spine, Mentorship, Movement, Inner circle, Texas Chiropractic College, Back pain, Patient, Diagnosis, Human, Vertigo, Chronic pain, Atascocita, Texas, Nursing

MOUNT BELVIEU, Texas, May 31, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Steven M. Carrell is acknowledged as a Distinguished Healthcare Professional for his contributions to the Chiropractic Field.

Key Points:

MOUNT BELVIEU, Texas, May 31, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Steven M. Carrell is acknowledged as a Distinguished Healthcare Professional for his contributions to the Chiropractic Field.
Dr. Carrell began his educational journey at Texas Chiropractic College where he earned his Bachelor of Science degree and his Doctor of Chiropractic degree in 2013.
He serves a regional population in the Mont Belvieu, Baytown, Dayton, Liberty, Crosby, Huffman, Atascocita, and Kingwood area.
With more than 9 years of experience in the field, Dr. Carrell works with patients of all ages to achieve relief from acute and chronic pain.

Aurora Spine Corporation Announces First Quarter Fiscal 2023 Financial Results

Retrieved on:

Wednesday, May 24, 2023

Aurora, ASG, Interest, Marketing, Silo, Spine, ZIP, TFX, Ortho, Investment, IRB, Patient, Trial of the century, DEXA, Neuro, Earnings, Zip, Total, Birth control, Mobile phone, Video game, Depreciation

CARLSBAD, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter fiscal 2023 ended March 31, 2023. All figures are in U.S. dollars.

Key Points:

CARLSBAD, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter fiscal 2023 ended March 31, 2023.
SiLO TFX – Initial surgeries using the SiLO TFX device occurred in March 2023 with a larger release scheduled in Q3 2023.
Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, “First quarter was a transitional quarter for Aurora, where the industry had to manage certain reimbursement changes that affected our SI joint division.
Total operating expenses were $2.191 million for the first quarter of 2023, compared to $2.288 million in the first quarter of 2022.

Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources

Retrieved on:

Tuesday, May 23, 2023

Surgeon, Workflow, Anatomy, ERAS, Spine, Marriott Marquis, Endoscopy, Instrument, Motion, Outpatient surgery, Robotics, New York Marriott Marquis, Complication, MIS, Conference, AR, International Society, Dentistry

DEERFIELD, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced today that it will be exhibiting at ISASS 2023 – the 23rd Annual Conference – sponsored by the International Society for Spine Surgery (“ISASS”) and Medical Education Resources. This three-day event will take place June 1-3, 2023 at the Marriott Marquis in San Francisco, CA.

Key Points:

DEERFIELD, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced today that it will be exhibiting at ISASS 2023 – the 23rd Annual Conference – sponsored by the International Society for Spine Surgery (“ISASS”) and Medical Education Resources.
This three-day event will take place June 1-3, 2023 at the Marriott Marquis in San Francisco, CA.
The International Society for the Advancement of Spine Surgery is dedicated to advancing major evolutionary steps in spine surgery.
In March 2023, the Company launched new advancements to its HOLO Portal system based on early clinical experiences and insights from leading spine surgeons in the U.S.

ZOLL remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional Use

Retrieved on:

Wednesday, May 24, 2023

ZOLL’s remedē System is an implantable transvenous phrenic nerve stimulation therapy for the treatment of adults with moderate to severe Central Sleep Apnea (CSA).

Key Points:

ZOLL’s remedē System is an implantable transvenous phrenic nerve stimulation therapy for the treatment of adults with moderate to severe Central Sleep Apnea (CSA).
Full-body MRI approval applies to all models of remedē System, covering new remedē patients as well as those who already have a remedē device.
Approval of the remedē System for conditional use with MRI will allow those patients to now have access to this important therapy,” said Dr. Asim Roy, medical director of the Ohio Sleep Medicine Institute.
FDA approval to use full-body MRI on remedē patients is a significant milestone for ZOLL and the remedē therapy.”
The remedē System was approved by the FDA in 2017.

GoHealthcare Practice Solutions LLC Joins athenahealth's Marketplace Program to Optimize Utilization Management and Streamline the Surgical Prior Authorization Process

Retrieved on:

Thursday, May 25, 2023

Marketplace, Policy, Spine, Surgical oncology, Patient, Nursing, Artificial intelligence, Empathy, Health, Health information management

FREEHOLD, N.J., May 25, 2023 /PRNewswire/ -- GoHealthcare Practice Solutions LLC, a provider of clinical and surgery coordination, prior authorization, utilization management and patient access services to interventional pain management, orthopedic & spine surgery, ambulatory surgery center and surgical oncology, today announced an agreement with athenahealth, Inc. through the company's Marketplace program. As part of the athenahealth® Marketplace, this newly integrated application is now available to athenahealth's growing network of healthcare providers to help increase provider productivity and increase patients satisfaction.

Key Points:

athenahealth clients can now leverage GoHealthcare Practice Solutions' strong team of 200+ experienced clinical nurses for prior authorization, utilization, patient access and surgery coordination.
That's why we work so hard for our patients," said Ms. Pinky Pescasio, CEO and managing director, GoHealthcare Practice Solutions.
As a Marketplace partner, GoHealthcare Practice Solutions LLC joins a community of innovative, like-minded healthcare professionals working to bring best-in-class solutions to the athenahealth provider base.
To learn more about GoHealthcare Practice Solutions LLC's new integrated services, please visit GoHealthcare Practice Solutions LLC's product listing page on the Marketplace .

Hoag Spine Center First to Offer EOSedge™ for Spine Imaging

Retrieved on:

Wednesday, May 24, 2023

EOS, Skeleton, Radiation, Surgeon, Shoulder, Hip, Workflow, Patient, 3D, Spine, Pain, Flex, Back pain, Rupture, Physician, Radiation exposure, Safety, Medical imaging, Nursing

NEWPORT BEACH, Calif., May 24, 2023 /PRNewswire/ -- Hoag Spine Center has become the first in Orange County to adopt the EOSedge System, a cutting-edge technology that combines multiple imaging techniques to better diagnose and treat back pain in adults.

Key Points:

The investment in this technology underscores Hoag Spine Center's dedication to understanding and treating the root cause of patients' conditions.
"The EOSedge is a remarkable advancement in musculoskeletal imaging, and we are thrilled to have this technology available to our patients."
Hoag's comprehensive Spine Center is a recognized leader and provider of the most advanced non-operative and minimally invasive treatment options available.
Hoag's board-certified, fellowship-trained spine experts provide personalized patient-centered care that enables them to achieve some of the best clinical outcomes in the nation.

Accomplished Scientist and Biosurgery Industry Veteran Dr. Neil Winterbottom Joins Medcura's Leadership Team

Retrieved on:

Wednesday, May 24, 2023

Partnership, University, Biochemistry, Powder, Spine, Research, Paralysis, Publication, Hemostasis, Risk, FDA, SVP, Nerve, Trauma, Medical device, Pharmaceutical industry

RIVERDALE, Md., May 24, 2023 /PRNewswire/ -- Medcura, Inc. has added Dr. Neil Winterbottom to its leadership team to accelerate the spine indication approval and commercialization of LifeGel™, Medcura's flagship surgical hemostat.

Key Points:

Medcura, Inc. is delighted to welcome biochemist Dr. Neil Winterbottom as its new SVP of Product Development & Manufacturing Operations.
Dr. Winterbottom has over 20 years of experience leading research and development teams from concept to commercialization, including teams working on sealants and hemostatic agents.
Dr. Winterbottom holds a doctorate degree in oral biology and biochemistry from the University of Alberta.
Neil has a proven track record of success in launching new hemostatic agents and surgical sealant products to the market.